Finance

Lists
532834:BOM
Camlin Fine Sciences Ltd
₹90,48
+0,54%
(+0,49) 1D
15 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532834...
Open
₹89,99
High
₹90,57
Low
₹88,53
Mkt. cap
17,36 ຕື້
Avg. vol.
45,19 ພັນ
Volume
95,31 ພັນ
P/E ratio
319,38
52-wk high
₹204,35
52-wk low
₹88,27
EPS
₹0,28
Shares outstanding
121,25 ລ້ານ
No. of employees
674
Open
₹89,99
High
₹90,57
Low
₹88,53
Mkt. cap
17,36 ຕື້
Avg. vol.
45,19 ພັນ
Volume
95,31 ພັນ
P/E ratio
319,38
52-wk high
₹204,35
52-wk low
₹88,27
EPS
₹0,28
Shares outstanding
121,25 ລ້ານ
No. of employees
674
News stories
From web sources and news partners
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees674
Founded1931
Headquarters-
SectorSpeciality chemicals
Last report
11 ສ.ຫ. 2026
Fiscal period
Q1 2027
₹-0,99 / ₹0,12
-921,17%miss
Revenue / Est. (INR)
5,20 ຕື້ / 5,11 ຕື້
+1,66%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
4,60 ຕື້
4,57 ຕື້
3,83 ຕື້
5,20 ຕື້
Cost of goods sold
2,47 ຕື້
2,48 ຕື້
2,24 ຕື້
3,06 ຕື້
Cost of revenue
2,47 ຕື້
2,48 ຕື້
2,24 ຕື້
3,06 ຕື້
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
602,93 ລ້ານ
637,64 ລ້ານ
886,99 ລ້ານ
734,29 ລ້ານ
Operating expense
1,99 ຕື້
2,04 ຕື້
1,52 ຕື້
2,16 ຕື້
Total operating expenses
4,45 ຕື້
4,52 ຕື້
3,76 ຕື້
5,21 ຕື້
Operating income
145,85 ລ້ານ
53,04 ລ້ານ
65,46 ລ້ານ
-15,12 ລ້ານ
Other non operating income
17,20 ລ້ານ
29,36 ລ້ານ
-94,79 ລ້ານ
13,40 ລ້ານ
EBT including unusual items
-923,00 ພັນ
-278,54 ລ້ານ
2,25 ລ້ານ
-322,59 ລ້ານ
EBT excluding unusual items
-923,00 ພັນ
-103,43 ລ້ານ
94,48 ລ້ານ
-211,49 ລ້ານ
Income tax expense
59,12 ລ້ານ
452,00 ພັນ
-64,02 ລ້ານ
-4,63 ລ້ານ
Effective tax rate
-6.405,31%
-0,16%
-2.849,31%
1,44%
Other operating expenses
1,19 ຕື້
1,23 ຕື້
449,93 ລ້ານ
1,23 ຕື້
Net income
-143,84 ລ້ານ
-362,30 ລ້ານ
882,02 ລ້ານ
-317,06 ລ້ານ
Net profit margin
-3,13%
-7,92%
23,05%
-6,10%
Earnings per share
-0,29
-0,94
0,76
-0,99
Interest and investment income
-
-
79,64 ລ້ານ
-
Interest expense
-152,05 ລ້ານ
-183,29 ລ້ານ
-76,78 ລ້ານ
-162,78 ລ້ານ
Net interest expenses
-152,05 ລ້ານ
-183,29 ລ້ານ
2,86 ລ້ານ
-162,78 ລ້ານ
Depreciation and amortization charges
188,27 ລ້ານ
167,28 ລ້ານ
184,44 ລ້ານ
191,56 ລ້ານ
EBITDA
324,59 ລ້ານ
203,20 ລ້ານ
199,10 ລ້ານ
118,52 ລ້ານ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google